Evidence map›Paper›PMID 28829050›Full record

ArticleImmunology and cell biology2017

Tamm-Horsfall glycoprotein engages human Siglec-9 to modulate neutrophil activation in the urinary tract.

Kathryn A Patras, Alison Coady, Joshua Olson, Syed Raza Ali, Satish P RamachandraRao, Satish Kumar, Ajit Varki, Victor Nizet

Open access · greenAbstract read
In one paragraph

Article in Immunology and cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 33 citations in OpenAlex.

  1. Urinary tract infections in children.Nature reviews. Urology · 2026
    Review
  2. Review
  3. Review
  4. Endocrine regulation of uromodulin in aging.Frontiers in endocrinology · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. The role of uromodulin in cardiovascular disease: a review.Frontiers in cardiovascular medicine · 2024
    Review
  11. The kidney protects against sepsis by producing systemic uromodulin.American journal of physiology. Renal physiology · 2022
    Article
  12. Article
  13. Article
  14. The immune responses to differentFrontiers in immunology · 2022
    Review
  15. Review
  16. Review
  17. Article
  18. Novel Models ofMicroorganisms · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kathryn A PatrasDivision of Host-Microbe Systems & Therapeutics, Department of Pediatrics, UC San Diego, La Jolla, CA, USA.
Alison CoadyDivision of Host-Microbe Systems & Therapeutics, Department of Pediatrics, UC San Diego, La Jolla, CA, USA.
Joshua OlsonDivision of Host-Microbe Systems & Therapeutics, Department of Pediatrics, UC San Diego, La Jolla, CA, USA.
Syed Raza AliDivision of Host-Microbe Systems & Therapeutics, Department of Pediatrics, UC San Diego, La Jolla, CA, USA.
Satish P RamachandraRaoDepartment of Cellular and Molecular Medicine, UC San Diego, La Jolla, CA, USA.
Satish KumarSection of Nephrology, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Ajit VarkiGlycobiology Research and Training Center, UC San Diego, La Jolla, CA, USA.ORCID 0000-0002-2206-975X
Victor NizetDivision of Host-Microbe Systems & Therapeutics, Department of Pediatrics, UC San Diego, La Jolla, CA, USA.ORCID 0000-0003-3847-0422
UC San Diego Health System · USOklahoma City VA Medical Center · USSri Devaraj Urs Medical College · IN

Funding

Siglec Modulation of Inflammatory ResponsesP01HL107150 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LE, DZUNG T · 2011 to 2017
$18.0M
Glycoprotein Remodeling in the Vasculopathy and Coagulopathy of SepsisR01HL125352 · NHLBI · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI MARTH, JAMEY, NIZET, VICTOR · 2014 to 2018
$3.6M
NHLBI NIH HHS P01 HL107150NHLBI NIH HHS R01 HL125352
6 · The paper itself

Abstract

Urinary tract infections are a major problem in human medicine for which better understanding of native immune defenses may reveal new pathways for therapeutic intervention. Tamm-Horsfall glycoprotein (THP), the most abundant urinary protein, interacts with bacteria including uropathogenic Escherichia coli (UPEC) as well host immune cells. In addition to its well-studied functions to antagonize bacterial colonization, we hypothesize that THP serves a critical host defense function through innate immune modulation. Using isolated human neutrophils, we found that THP binds neutrophils and that this interaction reduces reactive oxygen species generation, chemotaxis and killing of UPEC. We discovered that THP engages the inhibitory neutrophil receptor sialic acid-binding Ig-like lectin-9 (Siglec-9), and mouse functional ortholog Siglec-E, in a manner dependent on sialic acid on its N-glycan moieties. THP-null mice have significantly more neutrophils present in the urine compared with wild-type mice, both with and without the presence of inflammatory stimuli. These data support THP as an important negative regulator of neutrophil activation in the urinary tract, with dual functions to counteract bacterial colonization and suppress excessive inflammation within the urinary tract.

Indexed as

AnimalsAntigens, CDAntigens, Differentiation, B-LymphocyteBacteriolysisCells, CulturedChemotaxisEscherichia coliEscherichia coli InfectionsHumansImmunity, InnateImmunomodulationMiceMice, KnockoutN-Acetylneuraminic AcidNeutrophil ActivationNeutrophilsAntigens, CDAntigens, Differentiation, B-LymphocyteN-Acetylneuraminic AcidReactive Oxygen SpeciesSialic Acid Binding Immunoglobulin-like LectinsSIGLEC9 protein, humanSiglece protein, mouseUromodulin

Identifiers

PMID28829050
PMCPMC5698129
OpenAlexW2749209988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.